Wright, K. D., Zimmerman, M. A., Fine, E., Aspri, T., Kieran, M. W., & Chi, S. (2018). LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY. Neuro Oncol.

Wright, Karen D., Mary Ann Zimmerman, Elizabeth Fine, Tristan Aspri, Mark W. Kieran, και Susan Chi. "LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY." Neuro Oncol 2018.

Wright, Karen D., et al. "LGG-26. TYPE II BRAF INHIBITOR TAK-580 SHOWS PROMISE FOR UPCOMING CLINAL TRIAL AS EVIDENCED BY SINGLE PATIENT IND STUDY." Neuro Oncol 2018.